Work

A phase I and pharmacokinetic study of a CanAg-targeted immunoconjugate, HuC242-DM4, in patients with CanAg-expressing solid tumors

Year: 2007

Type: article

Study design: Clinical Trial

Source: Molecular Cancer Therapeutics

Authors: Kamalesh K. Sankhala, Alain C. Mita, Alejandro D. Ricart, Monica Mita, Chia Chi Lin, Leslie Wood, John Sarantopoulos, Chris H. Takimoto, Amita Patnaik, Albert Qin, S. Zildjian, Anthony Tolcher

Institution: South Texas Accelerated Research Therapeutics

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2249448939

FWCI:

Cites:

Cited by: 2

Related to: 10